baber/WOPTO huggingface dataset:
Patent AU-2020204320-A1 (AU)
Title: A switching device
Inventor: SPRITZENDORFER BERND
IPC: H01H21/22
Filed: 2020-06-29
Abstract: A switching device (1) has a housing-mounted contact (6), a movable contact 
(4), and a switch lock (2) with a latch (20), a latch support (22) and a latching 
location, wherein the switching device (1) furthermore has a switching lever (7) 
and a connecting rod (10) is mounted movably on the latch support (22), the 
connecting rod (10) comprises an end portion bearing against a first projection (11) 
of the switching lever (7) when the switching lever (7) is arranged in a stationary 
ON-position, the connecting rod (10) further comprises an actuating shoulder (29) 
bearing against a second projection (30) of the switching lever (7) when the hand 
switching lever (7) is in a non-stationary ON-position, with an actuation of the 
switching lever (7) for separating the contacts (4, 6) moves the connecting rod (10) 
and thereby releases the latching of the latching support (22) to the latch (20).  
29-Jun-20
1/4 
262 
01 
3-
19-aaaaaaaaaaaa 
r 14 
Fig. 1 7 2 
11 
01 
34---- 33 
19- 181111111III u u u u 
ag 0000 000008 
Fig. 2
Patent AU-2020204559-A1 (AU)
Title: Device for fixing biological soft tissue, and method for producing same
Inventor: MUKAI TOSHIJI
IPC: C22C23/04
Filed: 2020-07-08
Abstract: The purpose of the present invention is to provide a 
device for fixing biological soft tissue, the device being 
composed of a magnesium-based alloy material, wherein the 
device is endowed with strength and deformation performance 
for being used as a device for coupling biological soft tissue 
that has been cut or separated due to an incision or the like 
during a surgical procedure, and is completely degraded in 
vivo and discharged after adhesion of the soft tissue or after 
healing of the incision tissue. This device, composed of a 
magnesium-based alloy material, is composed of a ternary Mg 
alloy material of Mg-Ca-Zn. In the Mg alloy material, the Ca 
and Zn are contained within the solid-solubility limit with 
respect to the Mg. The remainder is composed of Mg and 
unavoidable impurities. The Zn content is 0.5 at% or less. The 
Ca and Zn content has a relationship of Ca:Zn=l:x (where x is 
1 to 3) by atom ratio. The crystal grain structure is 
equiaxed, the crystal grain size according to linear intercept 
being 30 to 250 pm.
Patent AU-2020209822-A1 (AU)
Title: Engineered aryl sulfate-dependent enzymes
Inventor: FERREIRA TARSIS GESTEIRA
IPC: C12N9/10
Filed: 2020-01-15
Abstract: The present invention provides several non-naturally occurring sulfotransferase enzymes that have been engineered to react with aryl sulfate compounds as sulfo group donors, instead of the natural substrate 3 '-phosphoadenosine 5'-phosphosulfate, and with heparosan-based polysaccharides, particularly heparan sulfate, as sulfo group acceptors. Each of the engineered sulfotransferase enzymes have a biological activity characterized by the position within the heparosan-based polysaccharide that receives the sulfo group, including glucosaminyl
Patent AU-2020230230-A1 (AU)
Title: Laparoscopic simulator
Inventor: VAN FLUTE JORDAN LUKE
IPC: G09B23/28
Filed: 2020-09-07
Abstract: An apparatus for laparoscopic surgical training, comprising: a physical 
simulator unit; a physical tissue model; and a computing and display unit; 
wherein the physical simulator unit comprises at least one side wall and a 
removable internal base plate; wherein the side wall comprises: a central 
opening through which a camera is arranged to view the removable internal 
base plate; and two or more laparoscopic surgical tools entry openings; 
wherein the internal base plate is arranged to hold the physical tissue model in 
the camera's field of view and in a position accessible to laparoscopic surgical 
tools when inserted in the two or more laparoscopic surgical tools entry 
openings; and wherein the computing and display unit is arranged to acquire 
video data from the camera and signal data from the physical tissue model, 
and to then utilise the data sets to generate and display in real-time a 
customised mixed reality or augmented video.
'1 
1/ 
1/ 
/ 
CA~ 
/ 
(~J 
CA~ 
01 ~
Patent AU-2020258868-A1 (AU)
Title: Infusion head with controlled release of secondary drug
Inventor: CARTER MARY TERESA
IPC: A61M5/142
Filed: 2020-04-15
Abstract: Drug infusion systems are disclosed including an infusion head configured to deliver a primary drug and a secondary drug to a patient's subcutaneous tissue. The secondary drug may be provided in a controlled-release material and/or a drug-containing reservoir. Methods for assembling and using such drug infusion systems are also disclosed. The secondary drug may extend the wear time of the drug infusion systems.
Patent AU-2020260510-A1 (AU)
Title: Surface cleaning apparatus
Inventor: PRUIETT JASON W
IPC: A47L9/28
Filed: 2020-10-29
Abstract: A surface cleaning apparatus includes a controller coupled to a sensor or a set of sensors 
that collects and transmits data to a remote computing device. The surface cleaning apparatus 
can use wireless or networking technology with a protocol for wireless communication with the 
remote computing device. The remote computing device is configured to identify an event at 
the surface cleaning apparatus and/or a change in the cycle of operation of the surface cleaning 
apparatus based on the transmitted data. Sensor data can be transmitted from the remote 
computing device to a different surface cleaning apparatus.  
-55-
1/21 
Cloud 
com puti ng/sto rage 
device 112 
110 
Remote 
sensor 114 
Network 
106 Device10 
10 11 
102 
V ~Tank full 120 
Connectivity 
Component 104 Turbidity 122 
Controller 100 Floor type 124 
Memory CPU Pump pressure 126 
Filter Status 128 
Wheel rotation 130 
Acoustic 132 
VAC 64 UI 32 
Usage 134 
FBrush motor8 Pump 78 
Soil type 136 
Accelerometer 138 
I----------------------------------------------------------
FIG.I1
Patent AU-2020284295-A1 (AU)
Title: Catheter assembly having an injection port and related methods
Inventor: CHENG KIAT JIN
IPC: A61M25/06
Filed: 2020-05-21
Abstract: A catheter assembly (29) including a catheter adapter (36). A body of the catheter adapter includes a distal end (40), a proximal end (42), and a first lumen (44) extending through the distal end and the proximal end. The catheter adapter includes a side port (46), which extends outwardly from the body. The side port includes a second lumen (48), which may be perpendicular to the first lumen. The catheter assembly includes a catheter (50) extending distally from the distal end of the body. The catheter assembly includes a valve (52) disposed within the first lumen. The valve includes an outer surface that is cylindrical and seals the first lumen from the second lumen. The catheter assembly includes a divider (54) disposed with the second lumen. The divider divides the second lumen into a plurality of openings (56) and increases a burst value of the valve.
Patent AU-2020316643-A1 (AU)
Title: N-methyl, N-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases
Inventor: KUTTRUFF CHRISTIAN
IPC: A61P11/00
Filed: 2020-07-21
Abstract: The present invention relates to N-methyl, N-(6-(methoxy)pyridazin-3- yl) amine derivatives as autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases such as e.g. idiopathic lung disease (IFF) or systemic sclerosis (SSc). The present description discloses the preparation of exemplary compounds (e.g. pages 57 to 75; examples 1.1 to 5) as well as relevant biological data thereof (e.g. pages 15 to 21, tables 1 to 9). An exemplary compound is e.g. l-(6-(4-(((6-((6-(trifluoromethyl) pyridin-3-yl)methoxy)pyridazin-3-yl)amino)methyl)phenyl)-2,6- diazaspiro[3.3]heptan-2-yl)ethan-l-one (example 1.1).
Patent AU-2020336765-A1 (AU)
Title: Chidamide pharmaceutical composition, preparation method therefor and application thereof
Inventor: LU XIANPING
IPC: A61K31/4406
Filed: 2020-08-27
Abstract: A chidamide pharmaceutical composition, a preparation method therefor and an application thereof. The pharmaceutical composition comprises chidamide and a medicinal enteric-coated excipient that serves as a carrier. In the composition, chidamide is used as a guest molecule, and the medicinal enteric-coated excipient is a carrier molecule. Oral pharmacokinetic testing on animals proves that the bioavailability of the composition containing chidamide and the medicinal enteric-coated excipient is greatly improved, while adverse reactions caused by a drug in the gastrointestinal tract are reduced; in addition, the dosage may be reduced while maintaining the curative effect, thus having more important clinical significance than commercially available chidamide tablets.
Patent AU-2020338423-A1 (AU)
Title: Flame control in an oxyfuel combustion process
Inventor: FETVEDT JEREMY ERON
IPC: F23C7/00
Filed: 2020-08-26
Abstract: The present disclosure provides for improving flame propagation in a combustor, particularly in a combustor for use in a power production system and method. At least one stream being passed into the combustor (e.g., a fuel, an oxidant, a diluent, a coolant, a working fluid, water, or steam) can be independently heated to a temperature that is about the autoignition temperature of the fuel or greater. Further, flame stabilization, including promoting ignition, can be improved as described herein through controlled addition of one or more NOx species into the combustor or combustion chamber.
Patent AU-2020346370-A1 (AU)
Title: Antibacterial compounds
Inventor: GUILLEMONT JÉRÔME ÉMILE GEORGES
IPC: A61P31/06
Filed: 2020-09-11
Abstract: The present invention relates to the following compounds wherein the integers are as defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of tuberculosis.
Patent AU-2020361741-A1 (AU)
Title: Transdermal compositions comprising cannabidiol (CBD) for use in the treatment of seizure disorders
Inventor: PLAKOGIANNIS FOTIOS
IPC: A61K31/05
Filed: 2020-10-08
Abstract: The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of cannabis that comprises at least 90 % (w/w) of cannabidiol. The transdermal compositions may take a number of different forms and incorporate various different excipients (such as propylene glycol and hexylene glycol). The seizure disorders treated include various types of treatment resistant epilepsy (TRE).
Patent AU-2020373163-A1 (AU)
Title: Internal combustion engine having targeted engine lubrication
Inventor: FOUNTAIN GRAHAM HARRY
IPC: F16C33/10
Filed: 2020-10-29
Abstract: An internal combustion engine, including a pair of opposed pistons, a pair of opposed cylinders, and an output shaft, wherein each of the pistons is arranged for reciprocating motion within a respective one of the cylinders, driven by combustion, and the pistons are coupled to the output shaft by a coupling such that said reciprocating motion of the pistons drives rotation of the output shaft, wherein the coupling includes a connecting rod coupled to the opposed pistons, and the coupling further includes a crankshaft rotatably mounted within a slider bearing, the slider bearing being formed of separable parts and having unitary sides for sliding contact within the connecting rod.
Patent WO-2021174305-A1 (WO)
Inventor: ALBERS RILEY A
IPC: E02F3/40
Filed: 2021-03-05
Abstract: A bucket (102) for an underground loading machine (100) includes an opened bucket front (116) and a concaved bucket back (118). To provide abrasive wear resistance, the bucket includes a paddle plate (200) joined to the bucket underside (198) of the bucket floor (150). The paddle plate (200) can have a trumpet-shape tapering from flared forward edge to a plate tail (204) disposed toward the concaved bucket back (118). The bucket may be configured as a wedge bottomed bucket and include a plurality of spacer wedges (240) disposed between and spacing apart the bucket underside (198) and the paddle plate (200).
Patent WO-2022040760-A1 (WO)
Inventor: SCHEINER RUPERT CHRISTIAN
IPC: A41D13/11
Filed: 2021-08-31
Abstract: A mask for use at an operating pressure substantially equal to atmospheric pressure includes a body with a three-dimensional shaped chamber that is configured to receive a user's mouth and nares and operate at the operating pressure. The mask also includes a nose seal portion that has an uppermost portion that contacts the user's nose along the user's sagittal plane and around at least a portion of the user's nares on an inferior side of the user's nose inferior to the user's nasal ridge. The mask also includes a positioning and stabilising structure to provide a force to hold the seal forming structure in position against the user. A portion of the positioning and stabilising structure directly contacts the user's face between the user's lip inferior and mental protuberance in use.
Patent AU-2021200081-A1 (AU)
Title: Nanoparticle compositions, formulations thereof, and uses therefor
Inventor: EDELSON JONATHAN
IPC: A61K9/51
Filed: 2021-01-07
Abstract: The present invention describes novel nanoparticle compositions, and systems and 
methods utilizing them for treating disorders and/or conditions. Methods generally 
involve administering nanoparticle compositions (e.g., nanoparticle compositions 
comprising at least one known therapeutic agent and/or independently active 
biologically active agent; and/or empty nanoparticle compositions) to a subject in need 
thereof.
Patent AU-2021201510-A1 (AU)
Title: Use of cannabidiol in the treatment of epilepsy
Inventor: GUY GEOFFREY
IPC: A61K45/06
Filed: 2021-03-10
Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous 
Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by 
5 generalised seizures or focal seizures with impairment. The disclosure further relates to the use 
of CBD in combination with one or more anti-epileptic drugs (AEDs).
Patent AU-2021201690-A1 (AU)
Title: Method, computer-implemented tool and power plant control device for detecting power production degradation of solar power plants and solar power plant system
Inventor: BAMBERGER JOACHIM
IPC: H02J3/00
Filed: 2021-03-17
Abstract: Method, computer-implemented tool and power plant control device 
for detecting power production degradation of solar power plants and 
solar power plant system 
Abstract 
In order to detect power production degradation of a solar power plant (SPP) with at least one 
photovoltaic module (PVM), by which the detection of power production degradation, affected 
for instance by long term aging or soiling of the photovoltaic module of the solar power plant, is 
automated and carried out sensorless, it is proposed to determine the degradation by calibrating 
local measurements of data related to module/plant-internal parameters (PT) such as irradiance I 
and temperature T or electric power P and temperature as measurement data (MD 1 ,ti, MDT,ti, 
MDP,ti against irradiance reference data (RD,ti) for instance satellite data in the form of weather 
data for the same time and then analyze a variation of the calibration.  
FIGURE 1
1/4 
cnE 
cu C-
Iz C.D 
Ul -C3~ ~ 
cn_ - - C) _ 
I w 
cu, 
I _ _ _ 
_ _ _ I 
I~C' w-7  _____ : 
IL ... ... ..  
-CI 
~A
-c I 
IU C_-) CI 
I~c _ cJ_3 
LI -- - - - - - - - - - - - - - - J
Patent AU-2021202610-A1 (AU)
Title: Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
Inventor: BATES CRAIG
IPC: A61K31/517
Filed: 2021-04-28
Abstract: The present application relates to methods of preparing Compound A: 
HN H 
N I N 
F 
(A), 
or a salt thereof, and a polymorph of Compound A dihydrochloride salt: 
HCI HH O" 
N N HCI 
/ F 
5
Patent AU-2021203417-A1 (AU)
Title: Hydrocarbon formation treatment micellar solutions
Inventor: SOUTHWELL JOHN EDMOND
IPC: C09K8/68
Filed: 2021-05-25
Abstract: A hydrocarbon formation treatment micellar solution fluid and its use in treating 
underperforming hydrocarbon formations is described and claimed. A hydrocarbon formation 
treatment micellar solution fluid wherein the micellar solution fluid comprises 
water, a non-terpene oil-based moiety, a brine resistant aqueous colloidal silica sol; and 
optionally a terpene or a terpenoid, wherein the brine resistant aqueous colloidal silica sol has 
silica particles with a surface that is functionalized with at least one moiety selected from the 
group consisting of a hydrophilic organosilane, a mixture of hydrophilic and hydrophobic 
organosilanes, or a polysiloxane oligomer, wherein the brine resistant aqueous colloidal silica sol 
passes at least two of three of these brine resistant tests: API Brine Visual, 24 Hour Seawater 
Visual and API Turbidity Meter, and wherein, when a terpene or terpenoid is present, the ratio of 
total water to terpene or terpenoid is at least about 15 to 1.
Patent AU-2021204310-A1 (AU)
Title: Fluid resistant textile seams
Inventor: ROWSE BRENDON
IPC: A41D31/102
Filed: 2021-06-24
Abstract: A flexible fluid-resistant or impermeable seam (1) and a method of manufacturing a 
flexible fluid-resistant or impermeable seam. The seam is formed from a flexible fluid
resistant or impermeable material. A flexible fluid-resistant or impermeable seam is 
formed in the material by welding a flexible fluid-resistant or impermeable tubular 
component (2) between the edges of flexible fluid-resistant or impermeable materials so 
as to join all the materials together within one flexible fluid-resistant or impermeable 
seam.  
Figure 1
1/2 
1 
A 
2 
B 43 
FIGURE 1 
1 
A 2 
B 4 3 7 5 6 
FIGURE 2
Patent AU-2021205277-A1 (AU)
Title: Variable discriminator threshold for ion detection
Inventor: FISHER WILLIAM
IPC: H01J49/26
Filed: 2021-01-06
Abstract: An example system includes an ion detector and a signal processing apparatus in communication with the ion detector. The ion detector is arranged to detect ions during operation of the system and to generate a signal pulse in response to the detection of an ion. The signal pulse has a peak amplitude related to at least one operational parameter of the system. The signal processing apparatus is configured to analyze signal pulses from the ion detector and determine information about the detected ions during operation of the system based on the signal pulses. The signal processing apparatus includes a discriminator circuit. The signal processing apparatus is programmed to vary a threshold of the discriminator circuit based on the at least one operational parameter of the system during operation of the system.
Patent AU-2021217816-A1 (AU)
Title: Combination therapy for treating MPS1
Inventor: GARCIA COLLAZO ANA MARÍA
IPC: C07D487/04
Filed: 2021-02-03
Abstract: The application is directed to compounds of formula (I) and their salts and solvates, wherein B, R
Patent AU-2021218797-A1 (AU)
Title: Vaccine and methods for detecting and preventing filariasis
Inventor: KALYANASUNDARAM RAMASWAMY
IPC: A61P33/00
Filed: 2021-02-12
Abstract: The present invention is a multivalent immunogenic composition for immunizing an animal against filariasis. In some embodiments, the antigens of the multivalent immunogenic composition are protein-based, DNA-based, or a combination thereof. This invention also provides a method and kit for detecting a filarial nematode and determining vaccine efficacy.
Patent AU-2021219343-A1 (AU)
Title: Modular control unit and systems comprising the same
Inventor: TOMASZEWSKI ADAM
IPC: G01V1/52
Filed: 2021-02-12
Abstract: A control unit can comprise a housing and circuitry disposed within the housing. The circuitry can comprise a communications module, a memory, and a processor in communication with the memory and the communications module. A power source can be disposed within the housing. An input port that is configured to mate with a complementary output of a sensor unit that is external to the housing. The input port can be in communication with the circuitry. The input port can be configured to interface with the sensor unit.
Patent AU-2021232728-A1 (AU)
Title: Exercise apparatus
Inventor: THACH MINH LOI
IPC: A63B21/008
Filed: 2021-09-15
Abstract: An exercise apparatus comprises at least one chamber having an internal cavity therein and 
a piston disposed in the internal cavity. The piston is in a sealed arrangement with an inner 
wall of the internal cavity and is adapted to slide therethrough between first and second 
chamber ends of the chamber. The apparatus also comprises a cable assembly that 
includes a grippable portion, wherein the cable assembly is connected to the piston for 
pulling the piston towards the second chamber end to create a vacuum in the internal cavity 
between the piston and the first chamber end. A portion of the cable assembly extends into 
the internal cavity when the piston slides towards the first chamber end.
Patent AU-2021236528-A1 (AU)
Title: Refrigerant-containing composition, use thereof and refrigerator comprising same, and method for operating said refrigerator
Inventor: ITANO MITSUSHI
IPC: C09K5/04
Filed: 2021-09-23
Abstract: Provided is a refrigerant composition having two types 
of performance, i.e., a coefficient of performance that is 
equivalent to that of R410A and a sufficiently low GWP. Provided 
5 is a composition comprising a refrigerant, the refrigerant 
comprising trans-1,2-difluoroethylene (HFO-1132(E)), 
trifluoroethylene (HFO-1123), and difluoromethane (R32) at 
specific concentrations.
Patent AU-2021236576-A1 (AU)
Title: Method and system for card link filtering
Inventor: O'DONNELL GERARD JOSEPH
IPC: G06Q20/40
Filed: 2021-09-24
Abstract: OF THE DISCLOSURE 
A method for providing transaction details for payment transactions indicative of offer 
redemption includes: receiving an offer listing including at least one merchant offer 
entry, wherein each entry includes an offer identifier and an indication of a valid 
merchant with which a corresponding offer for goods or services may be redeemed; 
receiving an offer linking notification including a consumer identifier and an indication 
of a selection of an offer corresponding to a specific merchant offer entry by a 
consumer associated with the consumer identifier; identifying a merchant identifier, 
wherein the merchant identifier corresponds to the valid merchant indicated in the 
specific merchant offer entry; storing a transaction processing rule, the rule including 
the identified merchant identifier and the consumer identifier; and transmitting 
transaction details for a payment transaction included in an authorization request, 
wherein the authorization request further includes at least the identified merchant 
identifier and the consumer identifier.
Patent AU-2021261917-A1 (AU)
Title: Phenyl urea derivatives as N-formyl peptide receptor modulators
Inventor: DUONG TIEN T
IPC: C07D257/04
Filed: 2021-11-04
Abstract: C\U \grs\AppDta\Raing\iMnage\Work\Recet\35569438AU Pheyl urea deivaivea N-for yl peptd reeptr duators ract(22179543.I).-4/11/2021 
PHENYL UREA DERIVATIVES AS N-FORMYL PEPTIDE RECEPTOR 
MODULATORS 
ABSTRACT 
The present invention relates to phenyl urea derivatives useful for the treatment of 
inflammatory diseases, pharmaceutical compositions containing them and their use as tools 
or as pharmaceuticals as modulators of the N-formyl peptide receptor (FPR), including FPR1 
and FPR2, or as selective agonists of the FPR Ireceptor.  
R6 
R5  R7 
O R2 Rx R 
0N 
R4 N N k pn W * ~H H _' 
R3 R 2a O 
Formula I
Patent AU-2021273520-A1 (AU)
Title: Antibodies to OPGL
Inventor: BOYLE WILLIAM J
IPC: C07D475/10
Filed: 2021-11-22
Abstract: Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of 
treating osteopenic disorders by administering a pharmaceutically effective amount of 
antibodies to OPGL are described. Methods of detecting the amount of OPGL in a 
sample using antibodies to OPGL are described.